Harmony Biosciences Holdings, a commercial stage biotech developing therapies for narcolepsy and other CNS disorders, filed on Monday with the SEC to raise up to $100 million in an initial public ...
45 clinical trial sites of the 60 sites selected across the U.S., Italy, France, Spain, and Switzerland open and enrolling patients HOUSTON, TX / ACCESSWIRE / May 25, 2023 / CNS Pharmaceuticals, Inc. ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback